Myriad to Present Three New Studies at the AUA Annual Meeting
SALT LAKE CITY, May 06, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that results from three studies will be featured at the American Urological Association …